GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $42,000 | +61.5% | 968 | +61.3% | 0.00% | +100.0% |
| Q4 2021 | $26,000 | +36.8% | 600 | +19.3% | 0.00% | 0.0% |
| Q3 2021 | $19,000 | -47.2% | 503 | -49.6% | 0.00% | -50.0% |
| Q4 2020 | $36,000 | +414.3% | 998 | +394.1% | 0.00% | +100.0% |
| Q4 2018 | $7,000 | 0.0% | 202 | +12.2% | 0.00% | +100.0% |
| Q3 2018 | $7,000 | 0.0% | 180 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $7,000 | -78.1% | 180 | -78.2% | 0.00% | -71.4% |
| Q1 2018 | $32,000 | -11.1% | 824 | -18.7% | 0.01% | -12.5% |
| Q4 2017 | $36,000 | +5.9% | 1,014 | +21.6% | 0.01% | -27.3% |
| Q3 2017 | $34,000 | +21.4% | 834 | +29.5% | 0.01% | 0.0% |
| Q2 2017 | $28,000 | -73.3% | 644 | -74.2% | 0.01% | -68.6% |
| Q1 2017 | $105,000 | +2000.0% | 2,494 | +1747.4% | 0.04% | +1650.0% |
| Q4 2016 | $5,000 | – | 135 | – | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2014 | $21,000 | – | 400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
| Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
| KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
| Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
| EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
| Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
| Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
| Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
| Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
| CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |